Comparative efficacy of escitalopram in the treatment of major depressive disorder
Open accessAbstract
BACKGROUND: Escitalopram is an allosteric selective serotonin reuptake inhibitor (SSRI) with some indication of superior efficacy in the treatment of major depressive disorder. In this systematic review, we critically evaluate the evidence for comparative efficacy and tolerability of escitalopram, focusing on pooled and meta-analysis studies. METHODS: A literature search was conducted for escitalopram studies that quantitatively synthesized data from comparative randomized controlled trials in MDD. Studies were excluded if they did not focus on efficacy, involved primarily subgroups of patients, or synthesized data included in subsequent studies. Outcomes extracted from the included studies were weighted mean difference or standard mean difference, response and remission rates, and withdrawal rate owing to adverse events. RESULTS: The search initially identified 24 eligible studies, of which 12 (six pooled analysis and six meta-analysis studies) met the criteria for review. The pooled and meta-analysis studies with citalopram showed significant but modest differences in favor of escitalopram, with weighted mean differences ranging from 1.13 to 1.73 points on the Montgomery Asberg Depression Rating Scale, response rate differences of 7.0%-8.3%, and remission rate differences of 5.1%-17.6%. Pooled analysis studies showed efficacy differences compared with duloxetine and with serotonin noradrenaline reuptake inhibitors combined, but meta-analysis studies did not. The effect sizes of the efficacy differences increased in the severely depressed patient subgroups. CONCLUSION: Based on pooled and meta-analysis studies, escitalopram demonstrates superior efficacy compared with citalopram and with SSRIs combined. Escitalopram shows similar efficacy to serotonin noradrenaline reuptake inhibitors but the number of trials in these comparisons is limited. Efficacy differences are modest but clinically relevant, especially in more severely depressed patients.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Zhang, Q., Wang, C., Zheng, M., Li, Y., Li, J., Zhang, L., Shang, X., & Yan, C. (2014) · Cerebrovascular Diseases · doi:10.1159/000369778 · Cited by 11,609 · see citing works
Projections of Global Mortality and Burden of Disease from 2002 to 2030
Mathers, C. D., & Loncar, D. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030442 · Cited by 11,386 · see citing works
Cipriani, A., Furukawa, T. A., Salanti, G., Geddes, J. R., Higgins, J. P., Churchill, R., Watanabe, N., Nakagawa, A., Omori, I. M., McGuire, H., et al. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60046-5 · Cited by 1,654 · see citing works
The Economic Burden of Depression in the United States: How Did It Change Between 1990 and 2000?
Greenberg, P. E., Kessler, R. C., Birnbaum, H. G., Leong, S. A., Lowe, S. W., Berglund, P. A., & Corey-Lisle, P. K. (2003) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v64n1211 · Cited by 1,280 · see citing works
Network meta‐analysis for indirect treatment comparisons
Lumley, T. (2002) · Statistics in Medicine · doi:10.1002/sim.1201 · Cited by 1,206 · see citing works
Evaluation of networks of randomized trials
Salanti, G., Higgins, J. P., Ades, A., & Ioannidis, J. P. (2008) · Statistical Methods in Medical Research · doi:10.1177/0962280207080643 · Cited by 1,078 · see citing works
Anderson, I. M., Ferrier, I. N., Baldwin, R., Cowen, P. J., Howard, L. M., Lewis, G., Matthews, K., McAllister-Williams, H., Peveler, R. C., Scott, J. L., et al. (2008) · Journal of Psychopharmacology · doi:10.1177/0269881107088441 · Cited by 901 · see citing works
Treatment-Emergent Sexual Dysfunction Related to Antidepressants: A Meta-Analysis
Serretti, A., & Chiesa, A. (2009) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e3181a5233f · Cited by 583 · see citing works
Sobocki, P., Jönsson, B., Angst, J., & Rehnberg, C. (2006) · PubMed · Cited by 533 · see citing works
Kennedy, S. H., Lam, R. W. M., Parikh, S. V., Patten, S. B., & Ravindran, A. V. (2009) · Journal of Affective Disorders · doi:10.1016/j.jad.2009.06.043 · Cited by 526 · see citing works
Self-citationLam, R. W., Kennedy, S. H., Grigoriadis, S., McIntyre, R. S., Milev, R., Ramasubbu, R., Parikh, S. V., Patten, S. B., & Ravindran, A. V. (2009) · Journal of Affective Disorders · doi:10.1016/j.jad.2009.06.041 · Cited by 431 · see citing works
Self-citationMajor Depressive Disorder Treatment Guidelines in America and Europe
Davidson, J. R. T. (2010) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.9058se1c.04gry · Cited by 344 · see citing works
The economic burden of mental health problems in Canada.
Stephens, T., & Joubert, N. (2001) · PubMed · Cited by 251 · see citing works
Escitalopram versus citalopram: the surprising role of the R-enantiomer
S�nchez, C., B�ges�, K. P., Ebert, B., Reines, E. H., & Bræstrup, C. (2004) · Psychopharmacology · doi:10.1007/s00213-004-1865-z · Cited by 247 · see citing works
Gartlehner, G., Gaynes, B. N., Hansen, R. A., Thieda, P., DeVeaugh‐Geiss, A., Krebs, E. E., Moore, C. G., Morgan, L. C., & Lohr, K. N. (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-149-10-200811180-00008 · Cited by 233 · see citing works
Escitalopram Therapy for Major Depression and Anxiety Disorders
Baldwin, D. S., Reines, E. H., Guiton, C., & Weiller, E. (2007) · Annals of Pharmacotherapy · doi:10.1345/aph.1k089 · Cited by 228 · see citing works
Kennedy, S. H., Andersen, H. F., & Lam, R. W. M. (2006) · Journal of Psychiatry and Neuroscience · doi:10.1139/jpn.0615 · Cited by 216 · see citing works
Self-citationMansari, M. E., Sánchez, C., Chouvet, G., Renaud, B., & Haddjeri, N. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300686 · Cited by 197 · see citing works
Moore, N. D., Verdoux, H., & Fantino, B. (2005) · International Clinical Psychopharmacology · doi:10.1097/00004850-200505000-00002 · Cited by 190 · see citing works
Escitalopram versus other antidepressive agents for depression
Cipriani, A., Santilli, C., Furukawa, T. A., Signoretti, A., Nakagawa, A., McGuire, H., Churchill, R., & Barbui, C. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006532.pub2 · Cited by 190 · see citing works
Gorman, J. M., Korotzer, A. R., & Su, G. (2002) · CNS Spectrums · doi:10.1017/s1092852900028595 · Cited by 170 · see citing works
Which antidepressants have demonstrated superior efficacy? A review of the evidence
Montgomery, S., Baldwin, D. S., Blier, P., Fineberg, N. A., Kasper, S. F., LADER, M. H., Lam, R. W. M., Lépine, J., Möller, H., Nutt, D., et al. (2007) · International Clinical Psychopharmacology · doi:10.1097/yic.0b013e3282eff7e0 · Cited by 165 · see citing works
Self-citationChen, F., Larsen, M. B., Sánchez, C., & Wiborg, O. (2004) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2004.08.008 · Cited by 149 · see citing works
Patten, S. B., Kennedy, S. H., Lam, R. W., O'Donovan, C., Filteau, M. J., Parikh, S. V., & Ravindran, A. V. (2009) · Journal of Affective Disorders · doi:10.1016/j.jad.2009.06.044 · Cited by 148 · see citing works
Self-citationWaugh, J., & Goa, K. L. (2003) · CNS Drugs · doi:10.2165/00023210-200317050-00004 · Cited by 143 · see citing works
Escitalopram in the treatment of major depressive disorder: A meta-analysis
Kennedy, S. H., Andersen, H. F., & Thase, M. E. (2008) · Current Medical Research and Opinion · doi:10.1185/03007990802622726 · Cited by 141 · see citing works
Sánchez, C. (2006) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/j.1742-7843.2006.pto_295.x · Cited by 128 · see citing works
Bupropion Extended Release Compared With Escitalopram
Clayton, A. H., Croft, H. A., Horrigan, J. P., Wightman, D. S., Krishen, A., Richard, N. E., & Modell, J. G. (2006) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v67n0507 · Cited by 127 · see citing works
Montgomery, S. A., & Möller, H.-J. (2009) · International Clinical Psychopharmacology · doi:10.1097/yic.0b013e32832a8eb2 · Cited by 121 · see citing works
Duru, G., & Fantino, B. (2008) · Current Medical Research and Opinion · doi:10.1185/030079908x291958 · Cited by 112 · see citing works
Boulenger, J.-P., Huusom, A. K. T., Florea, I., Bækdal, T. A., & Sarchiapone, M. (2006) · Current Medical Research and Opinion · doi:10.1185/030079906x115513 · Cited by 112 · see citing works
Lieberman, J. A., Greenhouse, J. B., Hamer, R. M., Krishnan, K. R. R., Nemeroff, C. B., Sheehan, D. V., Thase, M. E., & Keller, M. B. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300571 · Cited by 105 · see citing works
Onset of action of escitalopram compared with other antidepressants: results of a pooled analysis
Kasper, S., Spadone, C., Verpillat, P., & Angst, J. (2006) · International Clinical Psychopharmacology · doi:10.1097/01.yic.0000194375.42589.c3 · Cited by 100 · see citing works
Characterization of an allosteric citalopram‐binding site at the serotonin transporter
Chen, F., Larsen, M. B., Neubauer, H. A., Sánchez, C., Plenge, P., & Wiborg, O. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02835.x · Cited by 96 · see citing works
Lepola, U. M., Wade, A. G., & Andersen, H. F. (2004) · International Clinical Psychopharmacology · doi:10.1097/00004850-200405000-00005 · Cited by 91 · see citing works
Comparison of escitalopram and citalopram efficacy: A meta-analysis
Auquier, P., Robitail, S., Llorca, P., & Rive, B. (2003) · International Journal of Psychiatry in Clinical Practice · doi:10.1080/13651500310003408 · Cited by 76 · see citing works
Efficacy of escitalopram in patients with severe depression: a pooled analysis
Llorca, P., Azorin, J., Despiégel, N., & Verpillat, P. (2005) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2005.00440.x · Cited by 74 · see citing works
Stórustovu, S. I., Sánchez, C., Pörzgen, P., Brennum, L. T., Larsen, A. K., Pulis, M., & Ebert, B. (2004) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705738 · Cited by 62 · see citing works
Escitalopram versus venlafaxine XR in the treatment of depression
Montgomery, S., & Andersen, H. F. (2006) · International Clinical Psychopharmacology · doi:10.1097/00004850-200609000-00008 · Cited by 60 · see citing works
Using Metaanalysis to Evaluate Evidence: Practical Tips and Traps
Lam, R. W. M., & Kennedy, S. H. (2005) · The Canadian Journal of Psychiatry · doi:10.1177/070674370505000306 · Cited by 59 · see citing works
Self-citationBaseline severity of depression predicts antidepressant drug response relative to escitalopram
Kilts, C. D., Wade, A. G., Andersen, H. F., & Schlaepfer, T. E. (2009) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656560902849258 · Cited by 58 · see citing works
Soares, C. N., Thase, M. E., Clayton, A. H., Guico‐Pabia, C. J., Focht, K., Jiang, Q. L., Kornstein, S. G., Ninan, P. T., Kane, C. P., & Cohen, L. S. (2010) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0b013e3181d88962 · Cited by 57 · see citing works
Efficacy of escitalopram compared to citalopram: a meta-analysis
Montgomery, S., Hansen, T. F., & Kasper, S. F. (2010) · The International Journal of Neuropsychopharmacology · doi:10.1017/s146114571000115x · Cited by 54 · see citing works
Lam, R. W. M., & Andersen, H. (2006) · Pharmacopsychiatry · doi:10.1055/s-2006-949148 · Cited by 53 · see citing works
Self-citationThe onset of effect for escitalopram and its relevance for the clinical management of depression
Wade, A. G., & Andersen, H. F. (2006) · Current Medical Research and Opinion · doi:10.1185/030079906x148319 · Cited by 46 · see citing works
Mnie‐Filali, O., Mansari, M. E., Espana, A., Sánchez, C., & Haddjeri, N. (2005) · Neuroscience Letters · doi:10.1016/j.neulet.2005.10.044 · Cited by 45 · see citing works
Effective Dose of Escitalopram in ModerateversusSevere DSM-IV Major Depression
Bech, P., Andersen, H., & Wade, A. G. (2006) · Pharmacopsychiatry · doi:10.1055/s-2006-946702 · Cited by 43 · see citing works
Papakostas, G. I., & Larsen, K. G. (2010) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-010-0149-3 · Cited by 41 · see citing works
Managing depressive and anxiety disorders with escitalopram
Thase, M. E. (2006) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.7.4.429 · Cited by 37 · see citing works
Treatment Emergent Sexual Dysfunction Related to Antidepressants: A Meta-analysis
Chiesa, A., Serretti, A., Calati, R., & Ronchi, D. D. (2009) · European Psychiatry · doi:10.1016/s0924-9338(09)70732-1 · Cited by 37 · see citing works
R-citalopram prevents the neuronal adaptive changes induced by escitalopram
Mnie‐Filali, O., Faure, C., Mansari, M. E., Lambás‐Señas, L., Bérod, A., Zimmer, L., Sánchez, C., & Haddjeri, N. (2007) · Neuroreport · doi:10.1097/wnr.0b013e3282f04047 · Cited by 33 · see citing works
Kornstein, S. G., Li, D., Mao, Y., Larsson, S., Andersen, H. F., & Papakostas, G. I. (2009) · CNS Spectrums · doi:10.1017/s1092852900020320 · Cited by 32 · see citing works
Superiority of escitalopram to paroxetine in the treatment of depression
Kasper, S. F., Baldwin, D. S., Lönn, S. L., & Boulenger, J. (2009) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2008.12.003 · Cited by 32 · see citing works
Lam, R. W. M., Andersen, H. F., & Wade, A. G. (2008) · International Clinical Psychopharmacology · doi:10.1097/yic.0b013e3282ffdedc · Cited by 29 · see citing works
Self-citationTrkulja, V. (2010) · Croatian Medical Journal · doi:10.3325/cmj.2010.51.61 · Cited by 25 · see citing works
Wade, A. G., Schlaepfer, T. E., Andersen, H. F., & Kilts, C. D. (2008) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2008.09.008 · Cited by 23 · see citing works
Lam, R. W. M., Lönn, S. L., & Despiégel, N. (2010) · International Clinical Psychopharmacology · doi:10.1097/yic.0b013e32833948d8 · Cited by 22 · see citing works
Self-citationLançon, C., Sapin, C., Note, I. D., & Farisse, J. (2006) · International Journal of Psychiatry in Clinical Practice · doi:10.1080/13651500600579290 · Cited by 9 · see citing works
Duru, G., & Fantino, B. (2008) · European Psychiatry · doi:10.1016/j.eurpsy.2008.01.477 · Cited by 6 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Zhong, H., Haddjeri, N., & Sánchez, C. (2012) · Psychopharmacology · doi:10.1007/s00213-011-2463-5 · Cited by 105 · see citing works
5-HT2 ligands in the treatment of anxiety and depression
Quesseveur, G., Nguyen, H. T., Gardier, A. M., & Guiard, B. P. (2012) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2012.719872 · Cited by 84 · see citing works
Clinical pharmacology review of escitalopram for the treatment of depression
Pastoor, D., & Gobburu, J. V. S. (2013) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2014.863873 · Cited by 80 · see citing works
Campos, B., Rivetti, C., Kress, T., Barata, C., & Dircksen, H. (2016) · Environmental Science & Technology · doi:10.1021/acs.est.6b00826 · Cited by 80 · see citing works
Pae, C., Wang, S., Han, C., Lee, S.-J., Patkar, A. A., Masand, P. S., & Serretti, A. (2015) · Journal of Psychiatry and Neuroscience · doi:10.1503/jpn.140120 · Cited by 71 · see citing works
Effects of pharmaceutical medications on male fertility.
Brezina, P. R., Yunus, F. N., & Zhao, Y. (2012) · Europe PMC (PubMed Central) · Cited by 71 · see citing works
Lam, R. W., Parikh, S. V., Ramasubbu, R., Michalak, E. E., Tam, E. M., Axler, A., Yatham, L. N., Kennedy, S. H., & Manjunath, C. V. (2013) · British Journal of Psychiatry · doi:10.1192/bjp.bp.112.125237 · Cited by 56 · see citing works
Self-citationThe cardiovascular safety profile of escitalopram
Thase, M. E., Larsen, K. G., Reines, E. H., & Kennedy, S. H. (2013) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2013.05.011 · Cited by 54 · see citing works
Ademosun, A. O., Adebayo, A. A., & Oboh, G. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.01.022 · Cited by 50 · see citing works
Alkahtani, M. E., Aodah, A. H., Asab, O. A. A., Basit, A. W., Orlu, M., & Tawfik, E. A. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13060891 · Cited by 49 · see citing works
ElMazoudy, R. H., Abdelhameed, N. I., & ElMasry, A. (2015) · International Journal of Impotence Research · doi:10.1038/ijir.2015.16 · Cited by 23 · see citing works
Choice of Treatment with Antidepressants: Influencing Factors
Himmerich, H., & Wranik, D. W. (2012) · Current Pharmaceutical Design · doi:10.2174/138161212803523653 · Cited by 21 · see citing works
Shin, C., Jeon, S., Lee, S.-H., Pae, C., Hong, N., Lim, H., Patkar, A., Masand, P., An, H., & Han, C.-S. (2023) · Clinical Psychopharmacology and Neuroscience · doi:10.9758/cpn.2023.21.1.135 · Cited by 20 · see citing works
Peselow, E. D., Tobia, G., Karamians, R., Pizano, D., & IsHak, W. W. (2015) · Psychiatry Research · doi:10.1016/j.psychres.2014.11.022 · Cited by 19 · see citing works
Souery, D., Calati, R., Papageorgiou, K., Juven‐Wetzler, A., Gailledreau, J., Modavi, D., Sentissi, O., Pitchot, W., Papadimitriou, G. N., Dikeos, D. G., et al. (2014) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2014.987814 · Cited by 19 · see citing works
Chatterjee, S., Maity, N., Ghosal, M. K., Gupta, A. N., Sil, A., & Chakraborty, S. (2014) · Indian Journal of Pharmacology · doi:10.4103/0253-7613.135959 · Cited by 18 · see citing works
Flores-Serrano, A. G., Vila-Luna, M. L., Álvarez-Cervera, F. J., Heredia-López, F. J., Góngora-Alfaro, J. L., & Pineda, J. C. (2013) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2013.06.003 · Cited by 17 · see citing works
Ameliorative Effect of Moringa oleifera Extract on Male Fertility in Paroxetine Treated Rats
El-Sheikh, S. M. A., Khairy, M., Fadil, H. A., & Abo-Elmaaty, A. M. A. (2016) · Zagazig Veterinary Journal/Zagazig Veterinary Journal (Online) · doi:10.21608/zvjz.2016.7878 · Cited by 15 · see citing works
Benatti, C., Alboni, S., Blom, J. M. C., Gandolfi, F., Mendlewicz, J., Brunello, N., & Tascedda, F. (2014) · Behavioural Brain Research · doi:10.1016/j.bbr.2014.06.040 · Cited by 14 · see citing works
Ademosun, A. O., Adebayo, A. A., & Oboh, G. (2019) · Andrologia · doi:10.1111/and.13371 · Cited by 14 · see citing works
Treating a broader range of depressed adolescents with combined therapy
Foster, S., & Mohler‐Kuo, M. (2018) · Journal of Affective Disorders · doi:10.1016/j.jad.2018.08.027 · Cited by 12 · see citing works
Senashova, O., Reddy, A. P., Cameron, J. L., & Bethea, C. L. (2012) · Reproductive Sciences · doi:10.1177/1933719111430992 · Cited by 8 · see citing works
In vivo investigation of escitalopram's allosteric site on the serotonin transporter
Murray, K. E., Ressler, K. J., & Owens, M. J. (2015) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2015.11.010 · Cited by 8 · see citing works
Yin, B.-W., & Liu, Y. (2023) · The Tohoku Journal of Experimental Medicine · doi:10.1620/tjem.2023.j103 · Cited by 7 · see citing works
Berry, R. B. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-0326-9.00029-4 · Cited by 5 · see citing works
Zhang, H., Wu, Z., Cao, L., Su, Y., Wang, F., Hong, W., Cai, Y., Peng, D., & Fang, Y. (2021) · Journal of Affective Disorders · doi:10.1016/j.jad.2021.10.011 · Cited by 4 · see citing works
Ng, C. G., Wong, S. K., Loh, H. S., & Yee, A. H. A. (2014) · PubMed · doi:10.7417/ct.2014.1778 · Cited by 4 · see citing works
Selective-serotonin reuptake inhibitors
Wang, L. L., & Lam, R. W. M. (2012) · doi:10.2217/ebo.11.385 · Cited by 5 · see citing works
Self-citationEvaluación del consumo en antidepresivos en la población uruguaya entre 2010 y 2014.
Pagano, E., Domínguez, V., Speranza, N., Barboza, L., & Tamosiunas, G. (2021) · Revista Médica del Uruguay · doi:10.29193/rmu.37.3.3 · Cited by 3 · see citing works
Selective Serotonin Reuptake Inhibitors, are They All Equal? A Pharmacoepidemiological Study
Peron, E. P., & Hardouin, J.-B. (2016) · Advances in Pharmacoepidemiology & Drug Safety · doi:10.4172/2167-1052.1000203 · Cited by 2 · see citing works
Mishra, S., Mudgal, V., Bagul, K. R., Jain, P., & Pal, V. (2025) · Cureus · doi:10.7759/cureus.79365 · Cited by 1 · see citing works
Kodali, M., Lella, S., Bodepudi, S., Benerji, T., & Parvathaneni, K. M. (2021) · IP Indian Journal of Neurosciences · doi:10.18231/j.ijn.2021.004 · Cited by 1 · see citing works
Risk Assessment of QT Prolongation with Citalopram and Escitalopram: An Evidence Based Review
Pollmann, A. S., Bergman, J. C., & Lines, K. L. (2014) · Dalhousie Medical Journal · doi:10.15273/dmj.vol40no2.4536
- Authors
- Lam, R., & Ali
- Affiliations
- University of British Columbia (CA)
- University of British Columbia Hospital (CA)
- Corresponding author
- Lam, Raymond
- ORCID
- Lam, Raymond
- Venue
- Neuropsychiatric Disease and Treatment
- Publisher
- Informa UK Limited
- Published
- 2011-02
- Volume
- 7
- Pages
- 39
- ISSN
- 1176-6328 (ISSN-L)
- PMC
- PMC3056172
- OpenAlex
- W2075394137
- Cited by
- 33
- References
- 59
- Citations by year
- 2025: 1 · 2023: 2 · 2021: 4 · 2019: 2 · 2018: 1 · 2016: 3 · 2015: 3 · 2014: 6 · 2013: 4 · 2012: 5
- FWCI
- 3.98
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Neuropsychiatric Disease and Treatment (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Dove Medical Press (Taylor and Francis Group) (submittedVersion, cc-by-nc)
- Topics
- Health Sciences › Medicine › Pharmacology › Treatment of Major Depression
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Social Sciences › Psychology › Clinical Psychology › Psychotherapy Techniques and Applications
- Keywords
- escitalopram, major depressive disorder, selective serotonin reuptake inhibitors, citalopram, duloxetine, serotonin-norepinephrine reuptake inhibitors, antidepressant efficacy, drug tolerability, severe depression, pooled analysis, meta-analysis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
